Trial Profile
A Phase 2, Randomized, Double-Blind, Vehicle Controlled, Dose-Ranging Study of the Effect of DRM04B in Subjects With Axillary Hyperhidrosis
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Mar 2017
At a glance
- Drugs Glycopyrrolate (Primary)
- Indications Hyperhidrosis
- Focus Therapeutic Use
- Sponsors Dermira
- 17 Mar 2017 According to a Dermira media release, data from this study will be presented at 13th Annual Maui Derm for Dermatologists 2017 meeting.
- 05 Feb 2015 Results published in the Media Release.
- 05 Oct 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.